A novel generation of potent gamma-secretase modulators: Combat Alzheimer’s disease and Down syndrome–associated Alzheimer’s disease

A novel generation of potent gamma-secretase modulators: Combat Alzheimer’s disease and Down syndrome–associated Alzheimer’s disease

Saved in:

Bibliographic Details
Main Author:	Xu-Qiao Chen
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-01-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00918
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease
by: Gao Ning, et al.
Published: (2025-08-01)

Development of Alzheimer’s disease in Down syndrome
by: Octavio García, et al.
Published: (2025-08-01)

Developing Novel Beta-Secretase Inhibitors in a Computer Model as a Possible Treatment for Alzheimer’s Disease
by: Tassanee Ongtanasup, et al.
Published: (2025-01-01)

Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer’s Disease
by: Tatjana L. Rothhaar, et al.
Published: (2012-01-01)

Interferon signaling modulates Down syndrome-associated Alzheimer’s disease pathology in a mouse model
by: Paula Araya, et al.
Published: (2025-08-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
by: Hermien Acx, et al.
Published: (2017-06-01)

Stem cell-based therapeutic strategies for down syndrome and Alzheimer’s disease
by: Osama Hamadelseed, et al.
Published: (2025-08-01)

Behavioral and psychological symptoms of dementia and Alzheimer’s disease progression in Down syndrome
by: Melissa R. Jenkins, et al.
Published: (2025-04-01)

Design of novel pyrazole and benzofuran-based derivatives as potent acetylcholinesterase inhibitors for Alzheimer’s disease management
by: Mohamed El Fadili, et al.
Published: (2025-05-01)

S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.
by: Weiping Qin, et al.
Published: (2009-01-01)

P531: Family members' knowledge and perspectives on Alzheimer's disease in people with Down syndrome
by: Zihan Yan, et al.
Published: (2025-01-01)

Noninvasive Assessment of β‐Secretase Activity Through Click Chemistry‐Mediated Enrichment of Neuronal Extracellular Vesicles to Detect Alzheimer's Disease
by: Hyoyong Kim, et al.
Published: (2025-07-01)

Evaluation of Selected Plant Phenolics via Beta-Secretase-1 Inhibition, Molecular Docking, and Gene Expression Related to Alzheimer’s Disease
by: Tugba Uçar Akyürek, et al.
Published: (2024-10-01)

Innovations in noninvasive sensory stimulation treatments to combat Alzheimer's disease.
by: Jung M Park, et al.
Published: (2025-02-01)

Polyphenols and miRNA interplay: a novel approach to combat apoptosis and inflammation in Alzheimer’s disease
by: Minji Zhou, et al.
Published: (2025-05-01)

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease
by: Ana Matošević, et al.
Published: (2024-11-01)

Immune modulation to treat Alzheimer’s disease
by: Michael R. Duggan, et al.
Published: (2025-03-01)

Advances in the Synthetic Approaches to β‑Secretase (BACE-1) Inhibitors in Countering Alzheimer’s: A Comprehensive Review
by: Yogeesh M, et al.
Published: (2025-08-01)

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease
by: Laia Montoliu-Gaya, et al.
Published: (2025-07-01)

Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review
by: Charlotte Jacob, et al.
Published: (2025-01-01)

γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds
by: Johannes Trambauer, et al.
Published: (2025-02-01)

Decrease in p3‐Alcβ37 and p3‐Alcβ40, products of Alcadein β generated by γ‐secretase cleavages, in aged monkeys and patients with Alzheimer's disease
by: Saori Hata, et al.
Published: (2019-01-01)

Mapping the affective syndrome in Alzheimer’s disease
by: Elisa de Paula França Resende, et al.
Published: (2015-07-01)

VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?
by: Aleksandra Sowa, et al.
Published: (2025-05-01)

Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment
by: Nasimudeen R. Jabir, et al.
Published: (2021-01-01)

Correction: γ‑Secretase modulator resistance of an aggressive Alzheimer‑causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds
by: Johannes Trambauer, et al.
Published: (2025-04-01)

Cognitive markers for the distinction between asymptomatic and prodromal Alzheimer's disease in Down syndrome: Correlations with volumetric brain changes
by: Javier García‐Alba, et al.
Published: (2025-01-01)

Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic mice.
by: Inna Rabinovich-Nikitin, et al.
Published: (2012-01-01)

Alzheimer's disease
by: Cinthya Leite, et al.
Published: (2013-03-01)

Alzheimer's disease
by: N. N. Koberskaya
Published: (2019-06-01)

Investigating the eye in Down syndrome as a window to Alzheimer’s disease: the REVEAL protocol – a clinical cross-sectional study
by: Henrik Zetterberg, et al.
Published: (2025-07-01)

Hybrid Attention and Multiscale Module for Alzheimer's Disease Classification
by: WANG Yuanjun
Published: (2025-06-01)

Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
by: Sahar Balkhi, et al.
Published: (2025-02-01)

Re-evaluating the choice of gamma stimulation frequency for the potential treatment of Alzheimer's disease: Novel invisible spectral flicker evokes gamma responses at various frequencies.
by: Mark Alexander Henney, et al.
Published: (2025-01-01)

Presenilin-1 Familial Alzheimer Mutations Impair γ-Secretase Cleavage of APP Through Stabilized Enzyme–Substrate Complex Formation
by: Sujan Devkota, et al.
Published: (2025-07-01)

Apathy and Related Executive Syndromes in Dementia Associated with Parkinson’s Disease and in Alzheimer’s Disease
by: Dario Grossi, et al.
Published: (2013-01-01)

Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer’s Disease
by: Bin Zhou, et al.
Published: (2020-01-01)

Tip60 HAT activators as therapeutic modulators for Alzheimer’s disease
by: Akanksha Bhatnagar, et al.
Published: (2025-04-01)

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
by: Manoj Govindarajulu, et al.
Published: (2018-01-01)